Patient-reported outcome measurement in community-acquired pneumonia: feasibility of routine application in an elderly hospitalized population

被引：0
作者：
Melanie A. Lloyd
Clarice Y. Tang
Emily J. Callander
Edward D. Janus
Amalia Karahalios
Elizabeth H. Skinner
Stephanie Lowe
Harin A. Karunajeewa
机构：
[1] Western Health,Department of Physiotherapy
[2] The University of Melbourne,Melbourne Medical School – Western Precinct
[3] La Trobe University,Department of Physiotherapy
[4] Western Sydney University,Department of Physiotherapy
[5] Griffith University,School of Medicine
[6] Western Health,General Internal Medicine Unit
[7] Sunshine Hospital,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health
[8] The University of Melbourne,Department of Physiotherapy, Melbourne School of Health Sciences
[9] University of Melbourne,Department of Physiotherapy, School of Primary Care, Faculty of Medicine, Nursing and Health Sciences
[10] Monash University,undefined
[11] The Walter and Eliza Hall Institute of Medical Research,undefined
来源：
Pilot and Feasibility Studies | / 5卷
关键词：
Outcome assessment; Pneumonia; Aged; Multimorbidity; Comorbidity; Inpatients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 225 条
  • [1] Wootton DG(2017)A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days Eur Resp J 49 208-1323
  • [2] Dickinson L(2017)The impact of community-acquired pneumonia on the health-related quality-of-life in elderly BMC Infect Dis 17 1312-982
  • [3] Pertinez H(2015)Antibiotic treatment strategies for community-acquired pneumonia in adults New Engl J Med 372 975-1901
  • [4] Eneje O(2010)Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial Am J Resp Crit Care Med 181 1894-928
  • [5] Keogan L(2014)β-Lactam monotherapy vs β-lactam–macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial JAMA Intern Med 174 922-19
  • [6] Macfarlane L(2015)The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial BMJ Open 5 1-1172
  • [7] Mangen MJ(2012)Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial Arch Intern Med 172 1165-488
  • [8] Huijts SM(2013)The strategy that will fix health care Harv Bus Rev 91 476-781
  • [9] Bonten MJ(2006)Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia Chest 130 773-1971
  • [10] de Wit GA(2003)Evaluation of outcomes in community-acquired pneumonia: a guide for patients, physicians, and policy-makers Lancet Infect Dis 3 1963-208
12345678910